Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.

Bollano E, Täng MS, Hjalmarson A, Waagstein F, Andersson B.

Heart. 2003 Jun;89(6):621-4.

3.

Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.

Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M.

J Am Coll Cardiol. 2001 Oct;38(4):939-46.

4.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

5.

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.

Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS.

J Am Coll Cardiol. 1999 Nov 1;34(5):1522-8.

6.

Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C.

Vasc Health Risk Manag. 2007;3(1):31-7. Review.

7.

Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.

Triposkiadis F, Dalampiras P, Kelepeshis G, Skoularigis J, Sitafidis G.

Int J Clin Pharmacol Ther. 2008 Mar;46(3):136-9.

PMID:
18397684
8.

Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.

Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A; COMET Investigators..

Am Heart J. 2005 Feb;149(2):370-6.

PMID:
15846279
9.

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A; Carvedilol Or Metoprolol European Trial Investigators..

Lancet. 2003 Jul 5;362(9377):7-13.

PMID:
12853193
10.

Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.

Arslan S, Erol MK, Bozkurt E, Acikel M, Gundogdu F, Atesal S, Senocak H.

Int J Cardiovasc Imaging. 2007 Oct;23(5):549-55. Epub 2006 Dec 14.

PMID:
17171429
11.

Beta-blocker treatment of chronic heart failure: comparison of carvedilol and metoprolol.

Maack C, Elter T, Böhm M.

Congest Heart Fail. 2003 Sep-Oct;9(5):263-70. Review.

12.

Effect of carvedilol versus metoprolol CR/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a COX multivariate regression analysis.

Shen X, Nair CK, Aronow WS, Hee T, Esterbrooks DJ.

Am J Ther. 2013 May-Jun;20(3):247-53. doi: 10.1097/MJT.0b013e3181f2abb3.

PMID:
21642836
13.

Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.

Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.

Pharmacotherapy. 2009 Aug;29(8):883-90. doi: 10.1592/phco.29.8.883.

PMID:
19637941
14.

Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.

Lindenfeld J, Lowes BD, Bristow MR.

Ann Pharmacother. 1999 Dec;33(12):1266-9.

PMID:
10630826
15.

Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.

Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S.

Cardiovasc Ther. 2008 Fall;26(3):182-8. doi: 10.1111/j.1755-5922.2008.00050.x.

PMID:
18786088
16.

Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).

Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA; COMET investors..

Eur J Heart Fail. 2005 Jun;7(4):640-9.

17.
18.

Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.

Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.

Eur J Heart Fail. 2005 Jun;7(4):618-23.

19.

Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.

Kubo T, Azevedo ER, Newton GE, Parker JD, Floras JS.

J Am Coll Cardiol. 2001 Nov 1;38(5):1463-9.

20.

Supplemental Content

Support Center